Senior insider sale
Chief Financial Officer at AGIOS PHARMACEUTICALS, INC. — senior position signals high conviction
$253.2K
8.18K shares
What this filing means
JONES CECILIA plans to sell 8.18K shares of AGIOS PHARMACEUTICALS, INC. valued at approximately $253.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/2/2026ACC: 0001439222-26-000054
Officer· Chief Financial Officer
Since Mar 2026
8.18K
Shares to sell
$253.2K
Approx. market value
3.14K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Vesting of Restricted Stock Units
Not Applicable
4/2/2026
3.14KTotal acquired3.14K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/2/2026 | Vesting of Restricted Stock Units Not Applicable | 3.14K | — |
| Total | 3.14K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
5.04K
Market value
$145.8K
3/2/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
3.14K
Market value
$107.4K
4/2/2026
Total
Units
8.18K
Value
$253.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/2/2026 | 5.04K | $145.8K | — | Completed |
| Planned — Approximate Date | ||||
4/2/2026 | 3.14K | $107.4K | Nasdaq | Planned |
| Total | 8.18K | $253.2K | ||